BusinessPostCorner.com
No Result
View All Result
Sunday, July 6, 2025
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources
BusinessPostCorner.com
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources
No Result
View All Result
BusinessPostCorner.com
No Result
View All Result

Wegovy-maker Novo Nordisk abruptly ousts chief executive

May 16, 2025
in Business
Reading Time: 3 mins read
A A
0
Wegovy-maker Novo Nordisk abruptly ousts chief executive
ShareShareShareShareShare

Novo Nordisk, the company that makes Wegovy and Ozempic, is abruptly ousting its chief executive over concerns the firm is losing ground in the popular weight-loss drug market.

The firm’s market value has dropped by roughly half over the last year, as alternatives from competitors such as Eli Lilly gain traction.

Lars Fruergaard Jørgensen has led the company since 2017, overseeing its rise to become the most valuable company in Europe after the launch of its flagship anti-obesity drugs.

He will stay in the role until a successor is appointed.

The company said its controlling shareholder, the Novo Nordisk Foundation, had started talks about replacing Mr Jørgensen in recent weeks as a result of “market challenges” and the slide in its share price.

“Considering the recent market challenges, the share price decline, and the wish from the Novo Nordisk Foundation, the Novo Nordisk Board and Lars Fruergaard Jørgensen have jointly concluded that initiating a chief executive succession is in the best interest of the company and its shareholders,” the company said in a statement.

As part of the changes, the firm said that its former chief executive, Lars Rebien Sørensen, who now leads the Novo Nordisk Foundation, will also take on a greater role on the firm’s board.

Mr Jørgensen started at the company in 1991. In an interview with Danish broadcaster TV2, he said that he had not seen the decision coming, according to Reuters.

The move also caught many analysts off-guard.

On a conference call with board chair Helge Lund, they pressed him on whether there were other factors behind the decision and whether it indicated a lack of confidence in the firm’s strategy.

“Share price decline is not exactly something he can control so I was wondering if you can give some more detail on what exactly has driven this change right now,” said Danske Bank analyst Carsten Lonborg Madsen, noting that the company had had only a handful leaders since its start.

“This is something that has been going on since mid 2024,” he said, referring to the slide in share price value. “It just feels like there’s something that has gone pretty wrong here.”

“I’m sorry to belabour the point but I have to say that I’m confused by the discussion,” Seamus Fernandez of Guggenheim Securities said later. “If I were the next potential chief executive I would be very nervous to take the role.”

Mr Lund acknowledged that the decision might look abrupt, noting that up until now it had been anticipating a slower succession timeline.

He said the firm would make an announcement of a new leader “in due course” and it did not signal a change in the its strategy or plans.

“There is nothing more behind this,” he said.

Shares in the firm fell further after the announcement.

Since 2021, Novo Nordisk has more than doubled its sales. But growth has been slowing.

Last year, sales rose 25% to more than 290bn Danish kroner (£33bn), while profits were up roughly 20%.

The company earlier this month predicted sales growth between 13% and 21%, with growth in operating profit between 16% to 24%.

Credit: Source link

ShareTweetSendPinShare
Previous Post

Fertility benefits and the ROI of a comprehensive approach

Next Post

I-9 Compliance: What You Need to Know in 2025

Next Post
I-9 Compliance: What You Need to Know in 2025

I-9 Compliance: What You Need to Know in 2025

Tesla’s shock Q2 delivery surprise may have been driven by smaller unexpected markets, leaving Wall Street puzzled

Tesla’s shock Q2 delivery surprise may have been driven by smaller unexpected markets, leaving Wall Street puzzled

July 3, 2025
Ongoing CFO turnover is fueling higher pay for finance chiefs

Ongoing CFO turnover is fueling higher pay for finance chiefs

July 1, 2025
Stock market today: S&P 500, Nasdaq eye fresh highs as futures rise

Stock market today: S&P 500, Nasdaq eye fresh highs as futures rise

June 30, 2025
Secret Service in US expands a global push against crypto scams

Secret Service in US expands a global push against crypto scams

July 5, 2025
XRP Price Prediction: Despite Recent Slip, Ripple’s Institutional Push Targets  – What to Watch

XRP Price Prediction: Despite Recent Slip, Ripple’s Institutional Push Targets $10 – What to Watch

July 5, 2025
Home Office unaware if foreign workers leave UK after visas end, MPs say

Home Office unaware if foreign workers leave UK after visas end, MPs say

July 3, 2025
BusinessPostCorner.com

BusinessPostCorner.com is an online news portal that aims to share the latest news about following topics: Accounting, Tax, Business, Finance, Crypto, Management, Human resources and Marketing. Feel free to get in touch with us!

Recent News

Musk launches US political party to fight ‘one-party system’

Musk launches US political party to fight ‘one-party system’

July 6, 2025
Retail investors reap big gains from ‘buying the dip’ in US stocks

Retail investors reap big gains from ‘buying the dip’ in US stocks

July 6, 2025

Our Newsletter!

Loading
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2023 businesspostcorner.com - All Rights Reserved!

No Result
View All Result
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources

© 2023 businesspostcorner.com - All Rights Reserved!